Englisch

Subject ID, consent group, subject source, source subject ID, and affection status of participants with or without T2D and involved in the "Type 2 Diabetes in African Americans, GWAS and Exome Sequencing" project.

8 Formulare  
  1. StudyEvent: SEV1
    1. Subject ID, race, age, gender, BMI, consent form(s) signed by participants, age of type 2 diabetes Mellitus diagnosis, age of end stage renal disease diagnosis, age of hypertension diagnosis, duration of type 2 diabetes Mellitus since diagnosis, individual has reported that he/she is on dialysis, individual has reported hypertension, individual has diabetic retinopathy reported by ophthalmologist or laser treatment with photocoagulation, HBA1C, pc1, pc2, pc3, pc4, pc5, pc6, pc7, pc8, pc9, and pc10 of participants with T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
    2. Subject ID, race, age, gender, BMI, fasting blood sugar, consent form(s) signed by participant, participant is fasting when he has not had anything to eat or drink 12 hours prior to blood draw, pc1, pc2, pc3, pc4, pc5, pc6, pc7, pc8, pc9, and pc10 of participants without T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
    3. Subject ID, family ID, mother ID, father ID, gender, and monozygotic tween ID of participants with of without T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
    4. Subject ID, consent group, subject source, source subject ID, and affection status of participants with or without T2D and involved in the "Type 2 Diabetes in African Americans, GWAS and Exome Sequencing" project.
    5. Subject ID, sample ID, sample source, source sample ID, sample use, if sample was used in analysis, and reason why sample was used in analysis of participants with or without T2D and involved in the "Type 2 Diabetes in African Americans, GWAS and Exome Sequencing" project.
    6. Subject ID, gender, age, T2D, diabetes age of diagnosis at time of study, height, weight, BMI, consortium name, and cohort name of participants with or without T2D and involved in the "Type 2 Diabetes Genetic Exploration by Next-generation Sequencing in Multi-Ethnic Samples (T2D-GENES) Project 1: Wake Forest African American Type 2 Diabetes" project.
    7. Sample ID, body site where sample was obtained, analyte type, histological type of sample, sequencing center, and tumor status of participants with or without T2D and involved in the "Type 2 Diabetes Genetic Exploration by Next-generation Sequencing in Multi-Ethnic Samples (T2D-GENES) Project 1: Wake Forest African American Type 2 Diabetes" project.
    8. Sample ID, analyte type, body site, and tumor status of participants with or without T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
pht005636
Beschreibung

pht005636

Alias
UMLS CUI [1,1]
C3846158
Subject ID
Beschreibung

SUBJID

Datentyp

string

Alias
UMLS CUI [1,1]
C2348585
Consent group as determined by DAC
Beschreibung

CONSENT

Datentyp

text

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0441833
Source repository where subjects originate
Beschreibung

SUBJ_SOURCE

Datentyp

string

Alias
UMLS CUI [1,1]
C3847505
UMLS CUI [1,2]
C0449416
UMLS CUI [1,3]
C0681850
Subject ID used in the Source Repository
Beschreibung

SOURCE_SUBJID

Datentyp

string

Alias
UMLS CUI [1,1]
C2348585
UMLS CUI [1,2]
C3847505
UMLS CUI [1,3]
C0449416
Case control status of the subject
Beschreibung

AFFECTION_STATUS

Datentyp

text

Alias
UMLS CUI [1,1]
C3274646
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Subject ID, consent group, subject source, source subject ID, and affection status of participants with or without T2D and involved in the "Type 2 Diabetes in African Americans, GWAS and Exome Sequencing" project.

8 Formulare
  1. StudyEvent: SEV1
    1. Subject ID, race, age, gender, BMI, consent form(s) signed by participants, age of type 2 diabetes Mellitus diagnosis, age of end stage renal disease diagnosis, age of hypertension diagnosis, duration of type 2 diabetes Mellitus since diagnosis, individual has reported that he/she is on dialysis, individual has reported hypertension, individual has diabetic retinopathy reported by ophthalmologist or laser treatment with photocoagulation, HBA1C, pc1, pc2, pc3, pc4, pc5, pc6, pc7, pc8, pc9, and pc10 of participants with T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
    2. Subject ID, race, age, gender, BMI, fasting blood sugar, consent form(s) signed by participant, participant is fasting when he has not had anything to eat or drink 12 hours prior to blood draw, pc1, pc2, pc3, pc4, pc5, pc6, pc7, pc8, pc9, and pc10 of participants without T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
    3. Subject ID, family ID, mother ID, father ID, gender, and monozygotic tween ID of participants with of without T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
    4. Subject ID, consent group, subject source, source subject ID, and affection status of participants with or without T2D and involved in the "Type 2 Diabetes in African Americans, GWAS and Exome Sequencing" project.
    5. Subject ID, sample ID, sample source, source sample ID, sample use, if sample was used in analysis, and reason why sample was used in analysis of participants with or without T2D and involved in the "Type 2 Diabetes in African Americans, GWAS and Exome Sequencing" project.
    6. Subject ID, gender, age, T2D, diabetes age of diagnosis at time of study, height, weight, BMI, consortium name, and cohort name of participants with or without T2D and involved in the "Type 2 Diabetes Genetic Exploration by Next-generation Sequencing in Multi-Ethnic Samples (T2D-GENES) Project 1: Wake Forest African American Type 2 Diabetes" project.
    7. Sample ID, body site where sample was obtained, analyte type, histological type of sample, sequencing center, and tumor status of participants with or without T2D and involved in the "Type 2 Diabetes Genetic Exploration by Next-generation Sequencing in Multi-Ethnic Samples (T2D-GENES) Project 1: Wake Forest African American Type 2 Diabetes" project.
    8. Sample ID, analyte type, body site, and tumor status of participants with or without T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
pht005636
C3846158 (UMLS CUI [1,1])
SUBJID
Item
Subject ID
string
C2348585 (UMLS CUI [1,1])
Item
Consent group as determined by DAC
text
C0021430 (UMLS CUI [1,1])
C0441833 (UMLS CUI [1,2])
CONSENT
Code List
Consent group as determined by DAC
CL Item
Subjects did not participate in the study, did not complete a consent document and are included only for the pedigree structure and/or genotype controls, such as HapMap subjects (0)
C5418626 (UMLS CUI [1,1])
C0549184 (UMLS CUI [1,2])
C0009797 (UMLS CUI [1,3])
C0205257 (UMLS CUI [1,4])
C2700399 (UMLS CUI [1,5])
C0030761 (UMLS CUI [1,6])
C5418626 (UMLS CUI [2,1])
C0549184 (UMLS CUI [2,2])
C0009797 (UMLS CUI [2,3])
C0205257 (UMLS CUI [2,4])
C2700399 (UMLS CUI [2,5])
C0017431 (UMLS CUI [2,6])
C4553389 (UMLS CUI [2,7])
CL Item
Disease-Specific (Type 2 Diabetes, IRB, RD) (DS-T2D-IRB-RD) (1)
C4014362 (UMLS CUI [1,1])
C1820919 (UMLS CUI [1,2])
SUBJ_SOURCE
Item
Source repository where subjects originate
string
C3847505 (UMLS CUI [1,1])
C0449416 (UMLS CUI [1,2])
C0681850 (UMLS CUI [1,3])
SOURCE_SUBJID
Item
Subject ID used in the Source Repository
string
C2348585 (UMLS CUI [1,1])
C3847505 (UMLS CUI [1,2])
C0449416 (UMLS CUI [1,3])
Item
Case control status of the subject
text
C3274646 (UMLS CUI [1,1])
AFFECTION_STATUS
Code List
Case control status of the subject
CL Item
Control (1)
C3274648 (UMLS CUI [1,1])
CL Item
Case (2)
C3274647 (UMLS CUI [1,1])
Zum Seitenanfang zurückkehren